REFERENCIAS

1. Teka T, Kote M, Kejela G, Getachew T. Magnitude and Factors Associated with Precervical Cancer among Screened Women in Southern Ethiopia. Advances in Public Health. 2019;2019(23):1- 8. DOI: 10.1155/2019/5049752 [ Links ]

2. Taye BT, Mihret MS, Muche HA. Risk factors of precancerous cervical lesions: The role of women's socio-demographic, sexual behavior and body mass index in Amhara region referral hospitals; case-control study. PLoS One. 2021;16(3):e0249218. DOI: 10.1371/journal.pone.0249218 [ Links ]

3. Thakur A, Gupta B, Gupta A, Chauhan R. Risk Factors for Cancer Cervix among Rural Women of a Hilly State A Case-Control Study. Indian Journal of Public Health. 2015;59(1):45-8. DOI: 10.4103/0019-557X.152862 [ Links ]

4. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. DOI: 10.3322/caac.21660 [ Links ]

5. Dulla D, Daka D, Wakgari N. Knowledge about cervical cancer screening and its practice among female health care workers in Southern Ethiopia: A cross-sectional study. Int J Womens Health. 2017;22(9):365-72. DOI: 10.2147/IJWH.S132202 [ Links ]

6. Muñoz WR, Ramírez NGR. Análisis de la situación del Cáncer en el Perú, 2018. Centro Nacional de Epidemiología, Prevención y Control de Enfermedades Ministerio de Salud del Perú. Lima, Perú. 2022. https://www.dge.gob.pe/epipublic/uploads/asis/asis_2020_27_120833.pdf [ Links ]

7. Chen M, Wang H, Liang Y, Hu M, Li L. Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia. BMC Cancer. 2020;20(1):1-14. DOI: 10.1186/s12885-020-07265-7 [ Links ]

8. Hemmat N, Bannazadeh H. Association of human papillomavirus infection and inflammation in cervical cancer. Pathog Dis. 2019;77(5):ftz048. DOI: 10.1093/femspd/ftz048 [ Links ]

9. Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018;7(10):5217-36. DOI: 10.1002/cam4.1501 [ Links ]

10. Akinlotan M, Bolin JN, Helduser J, Ojinnaka C, Lichorad A, Mcclellan D. Cervical Cancer Screening Barriers and Risk Factor Knowledge Among Uninsured Women. J Community Heal. 2017;42(4):770-8. doi: 10.1007/s10900-017-0316-9 [ Links ]

11. Tsehay B, Afework M. Precancerous lesions of the cervix and its determinants among Ethiopian women: Systematic review and meta-analysis. Plos One. 2020; 15(10):e0240353. DOI: 10.1371/journal.pone.0240353 [ Links ]

12. Wudtisan J, Tantipalakorn C, Charoenkwan K, Sreshthaputra R, Srisomboon J. Factors Associated with Development of HighGrade Squamous Intraepithelial Lesions of the Uterine Cervix in Women Younger than 30 Years. Asian Pac J Cancer Prev. 2019;20(4):1031-6. DOI: 10.31557/APJCP.2019.20.4.1031 [ Links ]

13. Yamaguchi M, Sekine M, Hanley S, Kudo R, Hara M, Adachi S, et al. Risk factors for HPV infection and high-grade cervical disease in sexually active Japanese women. Sci Rep. 2021;11(1):1- 9. DOI: 10.1038/s41598-021-82354-6 [ Links ]

14. Ampofo A, Boyes A, Asibey S, Oldmeadow C, Mackenzie L. Prevalence and correlates of modifiable risk factors for cervical cancer and HPV infection among senior high school students in Ghana: a latent class analysis. BMC Public Health. 2023;340(23):2-12. DOI: 10.1186/s12889-022-14908-w [ Links ]

15. Nartey Y, Hill P, Amo-Antwi K, Asmah R, Nyarko K, Yarney J, et al. Recommendations for cervical cancer prevention and control in Ghana: public education and human papillomavirus vaccination. Ghana Med. J. 2018;52(2):94-102. DOI: 10.4314/gmj.v52i2.6 [ Links ]

16. Dibisa K, Dinka M, Moti L, Fetensa G. Precancerous lesion of the cervix and associated factors among women of west Wollega, west Ethiopia, 2022. Cancer Control. 2022; 29:1-11. DOI: 10.1177/10732748221117900 [ Links ]

17. Velazquez C, Kawasha A, Rios-Gonzales C. Prevalencia de precursores de cáncer de cuello uterino. Rev Salud Pública del Paraguay. 2018;8(2):15-20. DOI: 10.18004/rspp.2018 [ Links ]

18. Beyene T, Akibu M, Bekele H, Seyoum W. Risk factors for precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: Unmatched case-control study. PLoS One. 2021;16(7):e0254663. DOI: 10.1371/journal. pone.0254663 [ Links ]

19. Nkfusai N, Mubah T, Yankam B, Tambe T, Cumber S. Prevalence of precancerous cervical lesions in women attending Mezam Polyclinic Bamenda, Cameroon. Pan Afr Med J. 2019;32:174. DOI: 10.11604/pamj.2019.32.174.16895 [ Links ]

20. Galván M, Barragán M, Meléndez R. Factores de riesgo asociados a lesiones intraepiteliales escamosas de alto grado. Rev Salud Quintana Roo. 2013;24(2):6-10. https://salud.qroo.gob.mx/revista/revistas/24/1.pdf [ Links ]

21. Machida H, Blake EA, Eckhardt SE, Takiuchi T, Grubbs BH, Mikami M, et al. Trends in single women with malignancy of the uterine cervix in United States. J Gynecol Oncol. 2018;29(2):e24. DOI: 10.3802/jgo.2018.29.e24 [ Links ]

22. Machida H, Eckhardt S, Castaneda A, Blake E, Pham H, Roman L, et al. Single marital status and infectious mortality in women with cervical cancer in the United States. Int J Gynecol Cancer. 2017;27(8):1737-46. DOI: 10.1097/IGC.0000000000001068 [ Links ]

23. Legasu T, Temesgen K, Ayele Z, Chekole M, Bayou F, Fetene J, et al. Determinants of cervical cancer screening service utilization among women attending healthcare services in Amhara region referral hospitals: a case-control study. BMC Womens Health. 2022;22(1):484. DOI: 10.1186/s12905-022-02071-8 [ Links ]

24. Abarca-Gomez L, Salas-Estrada M, Calvo León D, Freer Vargas J, Cordero P. Factores asociados a las Alteraciones del test de Papanicolaou Costa Rica, 2009. Rev Costarr Salud Pública. Jun 2014;23:8-12. https://www.scielo.sa.cr/pdf/rcsp/v23n1/art03v23n1.pdf [ Links ]

25. Sequera VG, Mena M, Hollmann M, Mani E, Ramas V, Bonilla S, et al. Identifying populations most susceptible to get benefit from broadening the scope for prevention of cervical cancer: Example from Uruguay. Papillomavirus Res. 2018;5:122-7. DOI: 10.1016/j.pvr.2018.03.004 [ Links ]

26. Makuza J, Nsanzimana S, Muhimpundu M, Pace L, Ntaganira J, Riedel D. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J. 2015;22:26. DOI: 10.11604/pamj.2015.22.26.7116 [ Links ]

27. Marlow L, Ryan M, Waller J. Increasing the perceived relevance of cervical screening in older women who do not plan to attend screening. Sex Transm Infect. 2020;96(1):20-5. DOI: 10.1136/sextrans-2019-054120 [ Links ]

28. Treco I, Vieira V, da Silva J, Treco F, Ferreto L, Lucio L. Prevalence and factors associated to cervical changes in units from the Single Health System. Rev Gauch Enferm. 2021;42:1-11. DOI: 10.1590/1983-1447.2021.20200233. [ Links ]

29. Xu H, Egger S, Velentzis S, O'Connell D, Banks E, Darlington-Brown J, et al. Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia. Cancer Epidemiol. 2018;55:162-9. DOI: 10.1016/j.canep.2018.05.013 [ Links ]

30. Ding L, Liu C, Zhou Q, Feng M, Wang J. Association of estradiol and HPV/HPV16 infection with the occurrence of cervical squamous cell carcinoma. Oncol. Lett. 2019;17(3):3548-54. DOI: 10.3892/ol.2019.10005 [ Links ]